174 related articles for article (PubMed ID: 17825390)
1. Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology.
Li AJ; Elmore RG; Pavelka JC; Karlan BY
Gynecol Oncol; 2007 Dec; 107(3):420-3. PubMed ID: 17825390
[TBL] [Abstract][Full Text] [Related]
2. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
Li AJ; Karlan BY
Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
Li AJ; Scoles DR; Armstrong KU; Karlan BY
Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
[TBL] [Abstract][Full Text] [Related]
4. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
Li AJ; Baldwin RL; Karlan BY
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
[TBL] [Abstract][Full Text] [Related]
5. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
Li AJ; McAllister P; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
[TBL] [Abstract][Full Text] [Related]
6. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.
Rosa FE; dos Santos RM; Poli-Frederico RC; Canevari Rde A; Nishimoto IN; Magrin J; Rainho CA; Kowalski LP; Rogatto SR
Arch Oral Biol; 2007 Aug; 52(8):732-9. PubMed ID: 17321486
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on survival in epithelial ovarian cancer.
Pavelka JC; Brown RS; Karlan BY; Cass I; Leuchter RS; Lagasse LD; Li AJ
Cancer; 2006 Oct; 107(7):1520-4. PubMed ID: 16941453
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
[TBL] [Abstract][Full Text] [Related]
10. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
[TBL] [Abstract][Full Text] [Related]
11. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors.
Skírnisdóttir I; Sorbe B
Acta Obstet Gynecol Scand; 2010; 89(1):101-7. PubMed ID: 19878086
[TBL] [Abstract][Full Text] [Related]
12. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.
Levine DA; Boyd J
Cancer Res; 2001 Feb; 61(3):908-11. PubMed ID: 11221880
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor gene cytosine, adenine, and guanine trinucleotide repeats in patients with endometriosis.
Lattuada D; Viganò P; Somigliana E; Odorizzi MP; Vignali M; Di Blasio AM
J Soc Gynecol Investig; 2004 May; 11(4):237-40. PubMed ID: 15120698
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women.
Yu MW; Yang YC; Yang SY; Chang HC; Liaw YF; Lin SM; Liu CJ; Lee SD; Lin CL; Chen PJ; Lin SC; Chen CJ
Hepatology; 2002 Jul; 36(1):156-63. PubMed ID: 12085360
[TBL] [Abstract][Full Text] [Related]
15. The effect of obesity on survival in patients with ovarian cancer.
Matthews KS; Straughn JM; Kemper MK; Hoskins KE; Wang W; Rocconi RP
Gynecol Oncol; 2009 Feb; 112(2):389-93. PubMed ID: 19062080
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
17. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
[TBL] [Abstract][Full Text] [Related]
19. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
[TBL] [Abstract][Full Text] [Related]
20. [CAG microsatellite polymorphisms of androgen receptor gene and the stage and grade of prostate cancer].
Li C; Dong J; Guan W
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):217-9. PubMed ID: 11783090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]